ST百灵: 关于第六届董事会第十七次会议决议的公告

Meeting Overview - The sixth board of directors held its 17th meeting, convened by Chairman Jiang Wei, combining on-site and communication methods for voting [1] - Independent directors participated via communication methods [1] Resolutions Passed - The board approved the proposal to apply for the removal of other risk warnings, with a unanimous vote of 9 in favor [1] - The board approved a proposal for the company to provide guarantees for its subsidiary, Anshun Dajiankang Pharmaceutical Industry Operation Co., Ltd., which is applying for a loan of 148 million yuan from Guizhou Bank for a term of 2 years. The company will provide a guarantee of 81.4 million yuan, while another shareholder will provide a guarantee of 66.6 million yuan [1] - The board approved the proposal to convene the second extraordinary general meeting of shareholders in 2025, with a unanimous vote of 9 in favor [2]